Last reviewed · How we verify
NCT07012291
Clinical Performance Evaluation of Native Whole Blood Samples of Patients on DOACs With the Perosphere ClotChek™
trial testing Whole Blood Clotting Time in Coagulation in 150 participants. Currently enrolling.
1 June 2027
Quick facts
| Lead sponsor | Perosphere Technologies Inc. |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 20 June 2025 |
| Primary completion | 1 June 2027 |
| Estimated completion | 1 June 2027 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Whole Blood Clotting Time
- Whole Blood Clotting Time
Conditions studied
- Coagulation — all drugs for Coagulation →
Sponsor
Perosphere Technologies Inc.
Who can join
Adults 18 to 80, any sex, with Coagulation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Perosphere ClotChek™ system consists of a hand-held, battery-operated blood coagulation instrument and disposable test cuvettes for use at the point-of-care (POC). The instrument performs a whole blood clotting time (WBCT) test using freshly drawn, non-citrated whole blood. The purpose of the present study is to characterize the performance of the Perosphere ClotChek™ as a quantitative measurement of the WBCT in patients taking one of the following Direct Oral Anticoagulants (DOACs), rivaroxaban or apixaban.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07012291
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Whole Blood Clotting Time
Trials testing the same drug.
- NCT06582563 — Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants · not yet recruiting
Other recruiting trials for Coagulation
Currently open trials in the same condition.
- NCT07014722 — Contact Activation of Coagulation in Newly Inserted Central Venous Catheters · NA · recruiting
- NCT06513611 — Cellular Immunity, Neuroendocrine, and Inflammatory Factors for Clinical Prognosis in Acute Coronary Syndrome · recruiting
- NCT05865691 — Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease · recruiting
- NCT05853796 — Observational Dutch Young Symptomatic StrokE studY - nEXT · recruiting
Other Perosphere Technologies Inc. trials
Trials by the same sponsor.
- NCT06582563 — Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07012291 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Perosphere Technologies Inc.
- Last refreshed: 16 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07012291.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing